Covariance Biosciences, LLC

Covariance Biosciences, LLC, operating as Agriplex Genomics, is a small business limited liability company based in Cleveland, Ohio, that provides agricultural genomics and genotyping services to the U.S. Department of Agriculture as a prime contractor exclusively. The vendor delivers PLEXSEQ single nucleotide polymorphism (SNP) genotyping assays, DNA isolation, custom assay design, and genetic analysis for crop research and development, with a footprint anchored entirely in USDA set-asides and small business purchases.

Covariance Biosciences' federal customer base is purely concentrated within the Department of Agriculture Agricultural Research Service, which accounts for all 14 prime awards (combined potential value $165 thousand). The vendor's work splits across regional USDA-ARS offices — the Field Research Implementation and Information Delivery program unit represents 6 awards ($65 thousand), the Midwest Area 4 awards ($56 thousand), the Northeast Area 1 award ($24 thousand), and support functions the remainder. Two of the most recent awards exemplify the vendor's core capability: a $25 thousand Total Small Business purchase order from the Southeast Area (awarded September 10, 2026, completion October 30, 2026) for design and validation of a 5,000-SNP marker panel assay for sugarcane genomic research, updating an existing 3.5K-SNP panel and validating genotypes across 190 Florida clones; and a $6,720 Total Small Business purchase order from the Central Program Planning Coordination and Support program (awarded July 29, 2025, completion July 28, 2026) for sugarcane sequencing services. Earlier work includes a $24.8 thousand Total Small Business purchase order from the Midwest Area for genotyping soybean samples across 1,050-plus SNP positions and targeted 54-SNP analysis on 2,100 samples, and a $24 thousand order from the Northeast Area for SNP genotyping of soybean, sorghum, and other crops.

The vendor's classification against Testing Laboratories and Services (7 awards) and Research and Development in Biotechnology (3 awards) reflects its focus on wet-lab genotyping assays and genomic analysis rather than agricultural consulting or systems integration. Award volume has been episodic — two awards in 2022, three in 2023, two in 2024, and one in both 2025 and 2026 — with only one award (the September 2026 purchase order) facing recompete inside the next twenty-four months. Covariance Biosciences operates exclusively as a prime contractor with no subcontractor footprint in the source data, meaning the vendor does not sit on parent IDIQs, GWACs, or agency-wide vehicles and has no named teaming relationships. All awards are firm fixed-price purchase orders; one award used no set-aside designation, while the remainder employed Total Small Business set-asides.